Flavin Financial Services Inc. purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,496 shares of the healthcare conglomerate's stock, valued at approximately $2,274,000. UnitedHealth Group accounts for about 2.2% of Flavin Financial Services Inc.'s portfolio, making the stock its 16th biggest holding.
Several other large investors have also made changes to their positions in UNH. M&T Bank Corp lifted its stake in UnitedHealth Group by 13.4% in the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate's stock valued at $128,975,000 after buying an additional 26,074 shares during the period. Sugarloaf Wealth Management LLC lifted its stake in UnitedHealth Group by 17.6% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock valued at $4,025,000 after buying an additional 1,193 shares during the period. Benjamin Edwards Inc. lifted its stake in UnitedHealth Group by 1,275.3% in the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate's stock valued at $26,060,000 after buying an additional 41,308 shares during the period. Parsifal Capital Management LP acquired a new position in UnitedHealth Group in the third quarter valued at about $21,165,000. Finally, Signal Advisors Wealth LLC lifted its stake in UnitedHealth Group by 13.0% in the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock valued at $4,611,000 after buying an additional 1,051 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.
UNH has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a report on Tuesday, December 3rd. Morgan Stanley lowered their price target on UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating for the company in a report on Wednesday, October 16th. Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a report on Thursday, December 5th. TD Cowen increased their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a "buy" rating in a report on Friday, October 18th. Finally, HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a report on Friday, January 10th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Buy" and an average price target of $629.32.
Read Our Latest Stock Analysis on UNH
In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.33% of the company's stock.
UNH opened at $548.65 on Tuesday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The stock has a market cap of $504.91 billion, a price-to-earnings ratio of 35.40, a PEG ratio of 1.48 and a beta of 0.61. The business has a 50 day moving average of $536.17 and a 200-day moving average of $565.20. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm's revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period last year, the firm posted $5.83 EPS. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.53%. UnitedHealth Group's payout ratio is 54.19%.
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.